Zuckerberg and Chan pledge $3 bn to fight disease

Facebook co-founder, his wife will invest the amount over the next decade

Facebook CEO Mark Zuckerberg
Facebook CEO Mark Zuckerberg holds a pair of the touch controllers for the Oculus Rift virtual reality headsets on stage during the Facebook F8 conference in San Francisco, California. Photo: Reuters
Reuters San Francisco
Last Updated : Sep 23 2016 | 1:38 AM IST
Facebook Chief Executive Mark Zuckerberg and his wife Priscilla Chan on Wednesday pledged more than $3 billion toward a plan to "cure, prevent or manage all disease within our children's lifetime." Speaking through tears at a San Francisco event to announce the initiative, Chan said she hoped to spare parents the pain she had seen while delivering difficult news as a pediatrician.

"In those moments and in many others we're at the limit of what we understand about the human body and disease, the science behind medicine, the limit of our ability to alleviate suffering. We want to push back that boundary," she said.

The event was attended by business and political luminaries including former Microsoft Corp Chairman Bill Gates, San Francisco Mayor Ed Lee and California Lieutenant Governor Gavin Newsom.

Zuckerberg said science and the medical community have made rapid advancements over the last 50 years, including eradicating smallpox and nearly eliminating polio without the aid of modern technology.

"Today, just four kinds of diseases cause the majority of deaths," Zuckerberg added in a posting on his Facebook page, citing cancer, heart disease, infectious diseases and neurological diseases. "We can make progress on all of them with the right technology."

The plan includes creating a bioscience research center, called the Biohub, developing a chip to diagnose diseases, and ways to monitor the bloodstream continuously and map cell types in the body.

Chan and Zuckerberg will donate $600 million over the next decade to the Biohub in San Francisco, bringing together Bay-area researchers and scientists from the University of California at San Francisco, the University of California at Berkeley and Stanford University.

Two initial Biohub projects will be a Cell Atlas, a map of cells controlling the body's major organs, and the Infectious Disease Initiative to develop new tools, tests, vaccines and strategies for fighting diseases such as HIV, Ebola and Zika.

The Biohub will be led by University of California, San Francisco professor Joseph DeRisi and Stanford University professor Stephen Quake, whose work includes small molecule screening and biological measurements.

Dr Cori Bargmann, a Rockefeller University neuroscientist, will lead all of Chan Zuckerberg's science initiatives.

Any research, tools and material coming out of Biohub, which will work with a network of 10 to 15 laboratories across the world, will be "available to every scientist, everywhere," Bargmann said.

"If you take great people and set them loose on important problems in an intelligent way and give them a long time horizon there will be progress."

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Sep 23 2016 | 12:09 AM IST

Next Story